Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · June 01, 2022

Efficacy of Dupilumab in Chronic Prurigo and Chronic Idiopathic Pruritus

Journal of the European Academy of Dermatology and Venereology: JEADV

 

Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: A systematic review of current evidence and analysis of response predictors
J Eur Acad Dermatol Venereol 2022 May 15;[EPub Ahead of Print], M Gael, T Adam, M Mariano-Bourin, AC Bursztejn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading